Transnational EU-project CE4BIG on cluster management excellence and SME support draws to a close
A European network focussing on personalized medicine
With the goal of supporting the development of advanced therapies for personalized medicine and related industries, the four clusters have created a European partnership in this field. Through four joint trainings, two joint events and four (online) delegations, they were able to improve their cluster competences and services for members. Moreover, through lessons learned in joint activities and through sharing knowledge, cluster strategies and strategic processes were optimised. Together, these activities have led to each of the partners obtaining an ESCA label of Cluster Management Excellence, demonstrating the provision of top-quality and tailor-made support services for their members: Atlanpole Biotherapies received Bronze, KLSK and Biowin received Silver, and BioM received Gold.
Impact for SMEs and other Cluster Members
A series of activities have been organised for cluster members throughout the CE4BIG project:
7 companies benefitted from intensive training courses, some organised through the ClusterXChange programme | 29 cluster members & 6 cluster organisations participated in a Bioproduction networking week | 24 participants attended info sessions on European funding opportunities for SMEs in collaboration with European project CELIS | 41 participants participated in the Polish Life Science Open Space 2021 dedicated CE4BIG session on Health Technologies| 53 participants attended the CE4BIG session on “Green Transition in Life Sciences” during the BioM BioEntrepreneurship Summit week| Over 1300 participants coached individually or through joint info sessions about opportunities through the project | 25 companies pitched at events to find European partners | Over 30 B2B meetings were organised through the scheme (several additional meetings outside)
Through these CE4BIG activities, the aim was achieved, namely that European SMEs participated in training and info sessions, gained access to individual support and coaching, and had opportunities to find and exchange with European business partners.
What’s next?
The CE4BIG cluster partnership will continue to flourish and respond to European challenges in the field of personalized medicine through its LinkedIn page: Health Clusters for SMEs and its future joint strategy, focusing on the industry working in the field of 5P medicine, and ensuring our support to SMEs for access to public funding. The partnership hopes to expand to other European countries to become a competitive, world-class network of health clusters.
Since 1997, BioM is the central network organization for the biotechnology sector in Munich and Bavaria, commissioned by the Bavarian Ministry of Economic Affairs. Approximately 270 biotechnological and pharmaceutical companies are present in the metropolitan area of Munich. The core competence of the region is the development of innovative therapeutics and diagnostics, in particular for personalized healthcare.
As a non-profit organization, BioM supports the biotech community with its extensive network in a variety of ways. The cluster management acts as a centralized access point to connect Bavarian life science companies with relevant national and international partners.
BioM also supports Bavarian biotech companies at every stage of setting up their business. For this, BioM has developed a unique support program, tailor-made for aspiring start-ups and entrepreneurs in the life sciences sector – the virtual incubator BioM inQlab. In total, BioM has supported more than 200 start-up companies over the last 20 years.
In addition, BioM offers a variety of workshops, trainings and events on industry-specific topics.
BioM Biotech Cluster Development GmbH
Am Klopferspitz 19a
82152 Martinsried
Telefon: +49 (89) 899679-0
Telefax: +49 (89) 899679-79
http://www.bio-m.org
Head of Communications
Telefon: +49 (89) 899679-15
E-Mail: klingner@bio-m.org
Head of International Affairs
Telefon: +49 (0)89 / 89 96 79-29
E-Mail: wehnelt@bio-m.org
